中科信息(300678) - 2024 Q3 - 季度财报

Financial Performance - The company's operating revenue for the third quarter reached ¥66,667,630.21, an increase of 64.10% year-on-year[3] - The net profit attributable to shareholders decreased by 81.57% to ¥1,200,279.64 compared to the same period last year[3] - The net profit attributable to shareholders after deducting non-recurring gains and losses surged by 2,187.66% to ¥494,686.98[3] - Total operating revenue for the third quarter reached ¥218,236,369.58, an increase of 11.0% compared to ¥196,092,462.66 in the same period last year[17] - Net profit for the quarter was ¥5,093,497.45, a decrease of 76.0% from ¥21,220,184.31 in the previous year[18] - Earnings per share (EPS) for the quarter was ¥0.0209, down from ¥0.0919 in the same quarter last year[18] Assets and Liabilities - Total assets decreased by 18.27% to ¥1,032,248,383.79 compared to the end of the previous year[4] - The total assets of the company decreased from CNY 1,263,044,289.24 at the beginning of the period to CNY 1,032,248,383.79 at the end of the period, representing a decline of approximately 18.3%[14] - Current assets decreased from CNY 1,050,470,013.79 to CNY 829,162,976.84, a reduction of about 21%[14] - Total liabilities increased from CNY 600,000.00 to CNY 11,000,000.00 in short-term borrowings, indicating a significant rise[14] - Total liabilities decreased to ¥177,401,135.36 from ¥398,471,223.60, indicating a significant reduction in financial obligations[19] Cash Flow - The company's cash flow from operating activities showed a net outflow of ¥102,812,910.72, a decrease of 1.04% year-on-year[3] - Operating cash flow for the current period was -102,812,910.72 CNY, compared to -101,759,356.59 CNY in the previous period, indicating a slight increase in cash outflow[20] - Cash received from sales of goods and services was 291,931,852.17 CNY, down from 371,089,948.96 CNY in the previous period, reflecting a decrease of approximately 21.3%[20] - Cash paid for goods and services was 232,257,471.25 CNY, a decrease from 306,605,646.94 CNY, indicating a reduction of about 24.2%[20] - Cash inflow from financing activities totaled 12,500,000.00 CNY, a significant increase from 1,829,360.00 CNY in the previous period[21] Equity and Investments - The total equity attributable to shareholders decreased by 1.00% to ¥855,473,649.66 compared to the end of the previous year[4] - The company's total equity stood at ¥854,847,248.43, down from ¥864,573,065.64 year-on-year[19] - The company's long-term equity investments increased slightly from CNY 129,584,866.31 to CNY 130,355,503.82, an increase of about 0.6%[14] Research and Development - Research and development expenses increased by 38.53% compared to the same period last year, indicating a focus on innovation[8] - Research and development expenses increased to ¥25,996,448.75, representing a rise of 38.5% compared to ¥18,766,509.79 last year[17] Government Support - The company received government subsidies amounting to ¥181,726.62 during the reporting period[5] Shareholder Information - The company plans to lift restrictions on 3,365,823 shares by June 10, 2025, which are currently under lock-up due to non-public offerings[12] - The total number of restricted shares decreased from 12,376,973 to 10,837,361, with 1,539,612 shares released during the period[12]